InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,267.84
(
-0.74%
)
US TECH 100
18,150.00
(
-0.43%
)
Dow Jones
39,065.26
(
-1.53%
)
Brent Oil
81.15
(
-0.20%
)
Bitcoin
67,583.11
(
-0.50%
)
Post# of 36559
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Gatorca

Send PM Follow Ignore
Followers 21
Posts 1320
Boards Moderated 0
Alias Born 06/28/2020

Gatorca

Re: LT 1990 post# 23411

Sunday, 01/31/2021 1:11:22 PM

Sunday, January 31, 2021 1:11:22 PM

Post# of 36559
The development of a useful therapeutic treatment for COVID-19 would be substantial. As a low-market cap, non-vaccine COVID-19 therapeutic company currently undergoing a Phase 3 trial, Revive executives believe the company has strong growth potential as its Bucillamine trial meets safety and efficacy endpoints.
Just wanted to repost the USA Today News for any new investors smile

https://www.usatoday.com/story/sponsor-story/imperium-group/2021/01/25/revive-therapeutics-phase-3-clinical-trial-covid-19-treatment/6672439002/
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM

Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM

"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

Start posting your company's news
Only $200 per official company press release!